A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry

15.2K views

⸱

DOI:

10.3791/53205

⸱

December 8th, 2015

 ,  , 

* These authors contributed equally

In This Article

Summary

Cell-to-cell transfer of protein aggregates, or proteopathic seeds, may underlie the progression of pathology in neurodegenerative diseases. Here, a novel FRET flow cytometry assay is described that enables specific and sensitive detection of seeding activity from recombinant or biological samples.

Abstract

Increasing evidence supports transcellular propagation of toxic protein aggregates, or proteopathic seeds, as a mechanism for the initiation and progression of pathology in several neurodegenerative diseases, including Alzheimer's disease and the related tauopathies. The potentially critical role of tau seeds in disease progression strongly supports the need for a sensitive assay that readily detects seeding activity in biological samples.

By combining the specificity of fluorescence resonance energy transfer (FRET), the sensitivity of flow cytometry, and the stability of a monoclonal cell line, an ultra-sensitive seeding assay has been engineered and is compatible with seed detection from recombinant or biological samples, including human and mouse brain homogenates. The assay employs monoclonal HEK 293T cells that stably express the aggregation-prone repeat domain (RD) of tau harboring the disease-associated P301S mutation fused to either CFP or YFP, which produce a FRET signal upon protein aggregation. The uptake of proteopathic tau seeds (but not other proteins) into the biosensor cells stimulates aggregation of RD-CFP and RD-YFP, and flow cytometry sensitively and quantitatively monitors this aggregation-induced FRET. The assay detects femtomolar concentrations (monomer equivalent) of recombinant tau seeds, has a dynamic range spanning three orders of magnitude, and is compatible with brain homogenates from tauopathy transgenic mice and human tauopathy subjects. With slight modifications, the assay can also detect seeding activity of other proteopathic seeds, such as α-synuclein, and is also compatible with primary neuronal cultures. The ease, sensitivity, and broad applicability of FRET flow cytometry makes it useful to study a wide range of protein aggregation disorders.

Introduction

The accumulation of intracellular tau amyloids defines tauopathies such as Alzheimer's disease. In early disease stages, pathology is generally localized to discrete regions of the brain, but with disease progression, pathology invariably spreads along distinct neural networks1-5. Accumulating evidence suggests transcellular propagation of toxic protein aggregates underlies this pathology (reviewed in 6-10). In this model, proteopathic seeds (e.g., tau) are released from donor cells and enter neighboring cells, transforming native tau protein into the misfolded form via templated conformational change11-15. The assay descr....

Access restricted. Please log in or start a trial to view this content.

Protocol

NOTE: This protocol emphasizes the use of FRET flow cytometry for detecting seeding activity from mouse biological samples. It is also compatible with recombinant fibrils and human biological samples. Mouse euthanasia and brain harvesting was performed in accordance with IACUC-approved procedures.

1. Brain Extraction

  1. Following deep anesthetization with isoflurane (2%), perfuse a mouse with ice-cold PBS containing 0.03% heparin, and extract the brain following the details described in Gage et al.18
  2. Place extracted tissue in a cryo-vial, and snap freeze by placing in liquid nitrogen. Alternatively, freeze tissue on dry ic....

Access restricted. Please log in or start a trial to view this content.

Results

FRET flow cytometry enables sensitive, quantitative, and rapid detection of seeding activity from recombinant or biological samples. Assay setup is facile: monoclonal-derived stable cell lines expressing tau-RD-CFP/YFP are transduced with seed material, incubated for 24-48 hr, and subjected to flow cytometry analysis (Figure 1A). In the absence of seeds, biosensor cells maintain tau in a soluble, monomeric form (Figure 1B). In the presence of seeds, however, biosensor cells convert tau i.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The FRET flow cytometry system described here is a powerful tool for quickly and quantitatively assessing tau seeding activity. It requires only moderate cell culture experience and a working knowledge of FRET and flow cytometry. Other seeding assays, such as Thioflavin T - which exhibits enhanced fluorescence when bound to beta sheet structure - are laborious and require a pure, recombinant protein substrate. Additionally, in vitro seeding assays for tau are only semi-quantitative and generally insensitive to s.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

This assay has been licensed to Janssen Pharmaceuticals.

Acknowledgements

This work was supported by the Tau Consortium (M.I.D); National Institutes of Health Grant 1R01NS071835 (M.I.D.), a Department of Defense Grant PT110816 (to M.I.D.), 1F32NS087805 (to J.L.F.), and 1F31NS079039 (to B.B.H.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
TBSSigmaT5912
cOmplete Protease Inhibitors (EDTA-free)Roche4693159001
Cryo-vialsSarstedt72.694.006
Analytical BalanceMettler ToledoXSE 105DU
Weighing BoatsFisher Scientific13-735-743
15 ml conical tubeUSA Scientific1475-0501
Omni Sonic Ruptor Ultrasonic HomogenizerOmni International18-000-115
Micro-Tip for Ultrasonic HomogenizerOmni InternationalOR-T-156
2-PropanolFisher ScientificA451
Noise Cancelling Ear MuffsFisher Scientific19-145-412
KimwipesFisher ScientificS47299
1.5 ml tubesUSA Scientific1615-5510
Microcentrifuge Eppendorf5424 000.215
DPBSLife Technologies14190-136
DMEMLife Technologies11965-084
Fetal Bovine SerumHyCloneSH30071.03
Penicillin-StreptomycinLife Technologies15140-122
GlutaMaxLife Technologies35050-061
Trypsin-EDTALife Technologies25300-054
50 ml Conical TubesPhenix ResearchSS-PH15
25 ml reagent resevoirsVWR41428-954
Multi channel pipetFisher ScientificTI13-690-049
96 well flat bottom platesCorning3603
Opti-MEMLife Technologies31985-070
Lipofectamine 2000Invitrogen11668019
96 well round bottom platesCorning3788
16% ParaformaldehydeElectron Microscopy SciencesRT 15710
PBSSigma-AldrichP5493
EDTASigma-AldrichED2SS
HBSSLife Technologies14185-052
Sorvall ST 40 CentrifugeThermo Scientific75004509
BIOLiner Swinging Bucket RotorThermo Scientific75003796
HemacytometerVWR15170-172
MACSQuant VYB Flow CytomterMiltenyi Biotec130-096-116
Chill 96 RackMiltenyi Biotec130-094-459
Flow Jo analysis softwareFlow Jo
20 μl pipet tipsRaininGPS-L10
200 μl pipet tipsRaininGPS-250
1 ml pipet tipsRaininGPS-1000
200 μl pipet tipsUSA Scientific1111-1800
5 ml serological pipettPhenix ResearchSPG-606180
10 ml serological pipettPhenix ResearchSPG-607180
25 ml Serological pipettPhenix ResearchSPG-760180

References

  1. Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., Greicius, M. D. Neurodegenerative diseases target large-scale human brain networks. Neuron. 62 (1), 42-52 (2009).
  2. Zhou, J., Gennatas, E. D., Efstathios, D., Kramer, J. H., Miller, B. L., Seeley, W. W. Predicting Regional Neu....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Tau AggregationBiosensor CellsFlow Cytometry AnalysisFluorescence CompensationSeeding Activity DetectionRecombinant Tau SeedsBrain HomogenatesHEK 293T Cells